-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
August 05, 2010 - Evidence-based Practice Center Technical Brief Protocol
Project Title: Technical Brief - Use and Safety … It requires that the patient be placed in a tube lying flat, either prone or supine. … What are the potential safety issues and harms of positional MRI technologies? … i Types of patients/patient selection criteria: inclusion and exclusion criteria, characteristics
of … enrolled patients (demographics, disease spectrum).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
January 01, 2011 - report: author identification,
year of publication, study design characteristics, study
population, patient … different types of
neurothrombectomy devices, what are the
type(s) of devices, study designs and sizes,
patient … patient discharge. … We did not draw conclusions
regarding their effectiveness or safety. … the topic, including randomized
controlled trials to determine the optimal device(s) to
use, and the patient
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - safety evaluation. … , thus disrupting the current health care model for this patient population. … data
and postmarket safety evaluation—set forth by FDA. … data and postmarket safety evaluation—set forth by FDA. … would view lorcaserin if it demonstrates safety and efficacy in a
majority of patients.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - of administration would be unlikely to deter liraglutide use if it
demonstrates safety and efficacy … Duo positively if it demonstrates safety and efficacy in clinical trials. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … if it demonstrates both short- and long-term safety and efficacy in a
majority of patients.
-
effectivehealthcare-admin.ahrq.gov/products/recombinant-factor-viia/clinician
March 01, 2020 - rFVIIa) in the hospital setting has increased despite limited comparative data on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … Food and Drug Administration has approved rFVIIa for the treatment and prevention of bleeding in patients … results of this review are summarized here for use in your decisionmaking and in discussions with patients … Hemorrhage and Adult Cardiac Surgery
In-Hospital, Off-Label Use of rFVIIa
TE Events/Total Patients
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
May 01, 2024 - Director, General Patient Safety Program
Center for Quality Improvement and Patient
Safety
Agency … effectiveness of patient safety practices (PSPs). … safety progress,”7 a claim supported by a recent meta-
analysis indicating that as many as 1 in 20 patients … the purpose of improving patient safety. … safety practices
Patient Safety Practice Summary of Final Advice Categorization of Final Advice
1
-
effectivehealthcare-admin.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
May 01, 2020 - EHC
The Evidence-based Practice Centers
The Scientific Resource Center
Registry of Patient … incarcerated)
Intervention/Exposure
Any strategy (or adjunct to MAT) that impacts the retention of patients … Patient Navigation Models for Lung Cancer. Rapid Evidence Product. … Human Development Indices and Indicators: 2018 Statistical Update . 2018. … Safety Practices and Ratings by a Technical Expert Panel, 2023-2024
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
November 09, 2011 - , routine surveillance for patients at
admission
Identifying patients at risk for suicide
… safety practice is applied to a patient safety problem in
order to improve beneficial patient safety … Safety
Practice
Patient
Safety
Problem
Contexts
- Safety Culture, Teamwork,
Leadership … of Patient Safety Practices – Developing Criteria
3
I. … Assessing the Evidence for Context-Sensitive Effectiveness and Safety of Patient
Safety Practices:
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
December 01, 2014 - were uncertain regarding long-term safety and efficacy. … The yearly cost per patient would be about $13,000 at current pricing. … , which has yet to be established in this
patient population. … declining because of
safety concerns. … for similar reasons, but mentioned long-term safety as a concern.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - abuse by increasing the
perceived safety of a harmful behavior. … Commercial clients pay
annual licensing fees for CaringTXT, prorated on projected patient populations … CaringTXT annual licenses cost about $12,000 to $18,000 for an average-sized university or
college client … Across all client types, patients pay for text messages only if the service is not included
in their … As of June 2015, CaringTXT was in use by clients including
the University of Pittsburgh and the Central
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a
class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials
treated with epoetin alfa … analyzed individual patient data from 2,122 patients in 6 trials receiving darbepoetin
alpha finding … Study and Independent Patient Level Meta-Analysis Selection:
Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for
patients with cancer--meta-analysis based on individual patient data
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - are made in
the report, its conclusions should have clinical
applicability because they laid out the safety … Objective outcomes addressed include
esophagitis healing, ambulatory pH, other indicators of
reflux, … placebo
in improving asthma symptoms, nocturnal asthma, or
use of asthma medications, or in objective indicators … Administrative databases can
provide additional data for addressing long-term
safety issues. … Objective outcomes addressed include
esophagitis healing, ambulatory pH, other indicators of reflux,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - . ���
Increased risk for arterial thromboembolic
events, particularly at doses >40 µg/kg of
patient … though the effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient … rFVIIa) in the hospital setting has increased despite limited comparative data
on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … In-Hospital, Off-Label Use of rFVIIa
TE Events/Total Patients
(%)
Risk Difference Summary
Effect Size
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
August 01, 2015 - Patient Stakeholder
Baltimore, MD
Ruth Horowitz, M.D. … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Endpoint Classification: Safety
Study
Intervention Model: Single Group
Assignment … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
October 19, 2016 - Patient Safety in Ambulatory Settings. Technical
Brief No. 27. … And
appropriate anti-‐ coagulation was
not considered a safety issue, though patients are
hurt badly … Is this a big
problem affecting patients? Which issues cause the
most patient harm? … Guiding Question #1 concerned patient safety
practices. … This patient safety practice has already been adopted
by NQF’s Patient Safety Measures in 2007, approved
-
effectivehealthcare-admin.ahrq.gov/products/prehospital-airway-management/research
August 01, 2021 - EHC
The Evidence-based Practice Centers
The Scientific Resource Center
Registry of Patient … Construct comparisons that are more clearly defined by specific emergency types, patient groups, and … No conclusion was supported by high SOE for any comparison and patient group. … 14, 2021
Systematic Review
AHRQ and the National Highway Traffic Safety … Safety Practices and Ratings by a Technical Expert Panel, 2023-2024
Rapid Evidence Product
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
December 14, 2017 - Due to safety issues, the
use of leuprolide is limited for only 3 months. … bleeding and statistically significant improvements in
women’s symptom and health-related quality-of-life indicators … had
much less time to get pregnant than the myomectomy patients. … US patients are different than European (or other
patients) in that there is greater direct appeal by … pharma,
device companies and providers to the consumer (patient).
-
effectivehealthcare-admin.ahrq.gov/products/horizon-scan/research
July 01, 2019 - EHC
The Evidence-based Practice Centers
The Scientific Resource Center
Registry of Patient … Executive Summary
With funding from the American Recovery and Reinvestment Act of 2009 (ARRA) and the Patient-Centered … You Might Also Like
Research Protocol
Dec 12, 2024
Impact of Healthcare Worker Safety … White Paper
Jul 27, 2023
Making Healthcare Safer IV: Final Report on Prioritization of Patient … Safety Practices for a New Rapid Review or Rapid Response
Research Protocol
Jun 02, 2023